Assessment of Adherence to Imatinib and Health-Related Quality of Life Among Patients with Gastrointestinal Stromal Tumor: A Cross-Sectional Study in an Oncology Clinic in Malaysia-Reference-Cited by-同舟云学术

Assessment of Adherence to Imatinib and Health-Related Quality of Life Among Patients with Gastrointestinal Stromal Tumor: A Cross-Sectional Study in an Oncology Clinic in Malaysia

Published:2021-09 Issue: Volume:Volume 15 Page:2175-2184
ISSN:1177-889X
Container-title:Patient Preference and Adherence
language:en
Short-container-title:PPA

Author:

Chuah Paik Ling^ORCID,Jamal Nurnina Fareeha,Siew Chai Jin,Ahmad Bustamam Ros Suzanna,Jeyasingam Vaishnavi,Khong Khei Choong

Publisher

Informa UK Limited

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Social Sciences (miscellaneous),Medicine (miscellaneous)

Reference34 articles.

1. Gastrointestinal Stromal Tumors

2. Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial

3. Prospective Multicentric Randomized Phase III Study of Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors Comparing Interruption Versus Continuation of Treatment Beyond 1 Year: The French Sarcoma Group

4. World Health Organization. Adherence to Long-Term Therapies: evidence for Action; 2003. Available from: https://www.who.int/chp/knowledge/publications/adherence_full_report.pdf?ua=1. Accessed May 31, 2021.

5. Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imatinib adherence prediction using machine learning approach in patients with gastrointestinal stromal tumor;Cancer;2024-09-06

3. Clinicopathological, immunohistochemical, molecular-genetic and risk profiles of gastrointestinal stromal tumors in a cohort of Sudanese patients;African Health Sciences;2023-04-11

4. Primary Localized Gastrointestinal Stromal Tumors: Medication Adherence and Prognosis According to Gender;Patient Preference and Adherence;2022-08

5. Imatinib-associated skin rash is related to treatment outcome in patients with unresectable and/or metastatic gastrointestinal stromal tumor;Journal of Gastrointestinal Oncology;2022-02